Literature DB >> 9843007

The natural history of condyloma in children.

A L Allen1, E C Siegfried.   

Abstract

BACKGROUND: Condyloma acuminatum, an infection caused by human papillomavirus (HPV), has become one of the most common sexually transmitted diseases. Correspondingly, anogenital warts are more frequently diagnosed in children. Twenty-five years ago a landmark prospective study showed that untreated common cutaneous warts in children spontaneously regress within 2 years in two thirds of cases, but a similar study of condyloma has not been published. Several treatment options are available for condyloma in adults; none have been studied or approved by the US Food and Drug Administration for treatment of children.
OBJECTIVE: Our purpose was to review a cohort of children with condyloma to determine the natural history.
METHODS: Of 75 originally identified subjects with condyloma, 41 qualified for further retrospective or prospective evaluation, including distribution of lesions, duration of disease, gender, and treatment, if any.
RESULTS: Overall, condylomas in 31 of 41 children (76%) experienced resolution. Spontaneous resolution occurred within 5 years in 22 of 41 subjects (54%), including 6 of 8 (75%) who never received treatment, and 16 of 33 (49%) in whom treatment failed. In 9 of 33 treated children (27%), resolution occurred during treatment. Girls presented three times more often than boys and resolution occurred comparatively more often in girls.
CONCLUSION: Spontaneous resolution of pediatric condyloma occurred in more than half of our subjects. Nonintervention is a reasonable initial approach to managing venereal warts in children.

Entities:  

Mesh:

Year:  1998        PMID: 9843007     DOI: 10.1016/s0190-9622(98)70268-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

Review 2.  Human papillomavirus in infants: transmission, prevalence, and persistence.

Authors:  Delese E LaCour; Connie Trimble
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-05-20       Impact factor: 1.814

Review 3.  Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors:  J Zampella; B Cohen
Journal:  Skin Health Dis       Date:  2022-02-09

Review 4.  Human papilloma virus (HPV) infection in children and adolescents.

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

5.  Coexistence of Oncogenic Human Papillomavirus Genotypes in Condylomata Acuminata among Children and Adolescents.

Authors:  Enklajd Marsela; Angelika J Fischbeck; Johannes A Hildebrand; Rui Aoki; Lars E French; Andreas Wollenberg; Elisa Schmoeckel; Markus Reinholz
Journal:  Acta Derm Venereol       Date:  2020-02-25       Impact factor: 3.875

6.  Mucocutaneous warts in Middle Anatolia, Turkey: clinical presentations and therapeutic approaches.

Authors:  Müzeyyen Gönül; Emine Unal; Ayşegül Yalçınkaya Iyidal; Seray Çakmak; Arzu Kılıç; Ulker Gul; Pinar Doner
Journal:  Postepy Dermatol Alergol       Date:  2015-06-15       Impact factor: 1.837

7.  A Discussion of High-Risk HPV in a 6-Year-Old Female Survivor of Child Sexual Abuse.

Authors:  Connie D Cao; Lena Merjanian; Joelle Pierre; Adrian Balica
Journal:  Case Rep Obstet Gynecol       Date:  2017-05-23

Review 8.  Penile warts: an update on their evaluation and management.

Authors:  Alexander Kc Leung; Benjamin Barankin; Kin Fon Leong; Kam Lun Hon
Journal:  Drugs Context       Date:  2018-12-19

9.  Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts.

Authors:  Scott Guenthner; Wendy McFalda; Melita Tate; Kimberly Eads; Jayson Rieger; David K Glover; Cynthia Willson; Pamela Rumney; Ted Rosen; Jennifer Andres; Melissa Olivadoti
Journal:  Am J Clin Dermatol       Date:  2021-09-13       Impact factor: 7.403

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.